Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,277 | 144 | 99.8% |
| Education | $5.33 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $360.78 | 24 | $0 (2020) |
| Amgen Inc. | $231.01 | 13 | $0 (2019) |
| Gilead Sciences, Inc. | $183.11 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $178.84 | 11 | $0 (2020) |
| Novo Nordisk Inc | $154.18 | 10 | $0 (2020) |
| PFIZER INC. | $136.12 | 10 | $0 (2023) |
| Lilly USA, LLC | $129.33 | 10 | $0 (2020) |
| Astellas Pharma US Inc | $124.74 | 8 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $110.55 | 6 | $0 (2018) |
| Allergan, Inc. | $108.66 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.38 | 5 | Gilead Sciences, Inc. ($98.38) |
| 2023 | $153.31 | 6 | Gilead Sciences, Inc. ($84.73) |
| 2022 | $14.68 | 1 | Dexcom, Inc. ($14.68) |
| 2021 | $17.43 | 1 | DEXCOM, INC. ($17.43) |
| 2020 | $236.10 | 16 | Novo Nordisk Inc ($74.10) |
| 2019 | $516.12 | 34 | AstraZeneca Pharmaceuticals LP ($87.15) |
| 2018 | $625.56 | 41 | AstraZeneca Pharmaceuticals LP ($146.23) |
| 2017 | $621.13 | 41 | GlaxoSmithKline, LLC. ($90.96) |
All Payment Transactions
145 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.01 | General |
| 11/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.60 | General |
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.79 | General |
| 03/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 02/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.08 | General |
| 11/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $67.00 | General |
| 10/19/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: VACCINES | ||||||
| 10/19/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: VACCINES | ||||||
| 09/19/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.73 | General |
| 09/16/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Endocrinology | ||||||
| 08/10/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: General - Pain Management_NMD | ||||||
| 01/04/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Endocrinology | ||||||
| 11/14/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/30/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Neuroscience | ||||||
| 11/04/2020 | Lilly USA, LLC | EMGALITY (Drug), TRULICITY | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Neuroscience | ||||||
| 10/12/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Respiratory | ||||||
| 09/21/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 09/18/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Diabetes | ||||||
| 06/29/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Diabetes | ||||||
| 06/15/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: VACCINES | ||||||
| 03/09/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Diabetes | ||||||
| 03/02/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 02/25/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: VACCINE | ||||||
| 02/24/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 40 | 45 | $5,302 | $1,764 |
| 2021 | 14 | 1,301 | 1,850 | $309,970 | $126,203 |
| 2020 | 17 | 1,993 | 2,790 | $405,569 | $157,331 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 28 | $2,972 | $1,156 | 38.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 17 | 17 | $2,330 | $608.52 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 333 | 637 | $165,620 | $49,228 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 228 | 228 | $33,720 | $28,988 | 86.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 177 | 310 | $52,700 | $19,773 | 37.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 237 | 237 | $23,700 | $19,229 | 81.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 39 | 39 | $2,925 | $2,541 | 86.9% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 14 | 14 | $5,650 | $1,446 | 25.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 70 | 125 | $9,250 | $1,214 | 13.1% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 64 | 64 | $1,600 | $1,155 | 72.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 13 | 13 | $5,850 | $1,110 | 19.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 39 | 39 | $1,560 | $614.03 | 39.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 64 | $3,328 | $518.10 | 15.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 18 | 21 | $2,205 | $226.20 | 10.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 38 | 42 | $1,386 | $94.50 | 6.8% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 14 | 17 | $476.00 | $66.81 | 14.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 378 | 710 | $184,600 | $49,628 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 290 | 290 | $34,830 | $32,317 | 92.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 291 | 610 | $103,700 | $29,740 | 28.7% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 300 | 300 | $30,000 | $24,815 | 82.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 173 | 174 | $13,050 | $10,554 | 80.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 176 | 177 | $7,080 | $2,814 | 39.7% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 11 | 11 | $2,860 | $2,452 | 85.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 78 | 155 | $11,470 | $1,486 | 13.0% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 65 | 65 | $1,625 | $1,159 | 71.3% |
About Dr. Thomas Kias, MD
Dr. Thomas Kias, MD is a Internal Medicine healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609848373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Kias, MD has received a total of $2,283 in payments from pharmaceutical and medical device companies, with $98.38 received in 2024. These payments were reported across 145 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,277).
As a Medicare-enrolled provider, Kias has provided services to 3,334 Medicare beneficiaries, totaling 4,685 services with total Medicare billing of $285,298. Data is available for 3 years (2020–2022), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Athens, GA
- Active Since 02/06/2006
- Last Updated 06/30/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609848373
Products in Payments
- FARXIGA (Drug) $218.70
- Prolia (Biological) $106.81
- MYRBETRIQ (Drug) $94.60
- Aimovig (Biological) $84.62
- SYMBICORT (Drug) $78.02
- BREO (Drug) $77.77
- Ozempic (Drug) $76.39
- TOUJEO (Drug) $75.72
- Vascepa (Drug) $73.95
- TRADJENTA (Drug) $69.29
- TRULICITY (Drug) $65.47
- VRAYLAR (Drug) $52.79
- ANORO (Drug) $52.58
- PNEUMOVAX 23 (Biological) $51.66
- Victoza (Drug) $48.96
- CHANTIX (Drug) $48.36
- CONTRAVE (Drug) $47.35
- iPro2 (Device) $44.85
- NAMZARIC (Drug) $42.96
- PREVNAR - 13 (Biological) $42.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Athens
Dr. Catherine Marti, Md, MD
Internal Medicine — Payments: $295,383
Kent Nilsson, M.d, M.D
Internal Medicine — Payments: $175,364
Petros Nikolinakos, M.d, M.D
Internal Medicine — Payments: $151,381
Karan Julka, Md, MD
Internal Medicine — Payments: $69,118
Antonio Sotolongo, M.d, M.D
Internal Medicine — Payments: $47,039
Asif Qadri, M.d, M.D
Internal Medicine — Payments: $46,806